Gold prices steady ahead of Fed decision, Trump’s tariff deadline
Cathie Wood’s ARK ETFs have again made notable moves in the financial and biotech sectors, as seen in their daily trades for Friday, February 21, 2025. Leading the day’s activity, ARK’s ARKF ETF invested heavily in Nu Holdings Ltd (NYSE:NU), acquiring a total of 162,143 shares with a dollar value of approximately $2.16 million. This purchase signals a strong belief in the digital banking platform, which has seen a consistent increase in ARK’s holdings.
On the other end of the spectrum, ARK’s ARKF ETF parted ways with 347 shares of the e-commerce giant MercadoLibre Inc (NASDAQ:MELI), totaling around $732,333. This sell-off comes amidst a recent pattern of trimming positions in larger, established tech companies.
Beam Therapeutics Inc (NASDAQ:BEAM) also continued to attract ARK’s attention, with a combined purchase of 24,640 shares across the ARKK and ARKG ETFs, amounting to $816,569. This follows a string of investments in Beam Therapeutics, highlighting ARK’s ongoing interest in the company’s gene-editing technology.
However, Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw a decrease in ARK’s holdings, with the ARKG ETF selling 8,129 shares, valued at $67,714. This sale is part of a trend, as ARK has been reducing its stake in Adaptive Biotechnologies over the past week.
Investors following ARK’s trades will notice a pattern of increasing positions in innovative biotech firms like Beam Therapeutics, while cautiously adjusting holdings in other areas such as digital banking with Nu Holdings and e-commerce with MercadoLibre. These moves reflect ARK’s strategy of focusing on disruptive innovation and growth potential in a rapidly evolving market landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.